Postgraduate Course: Commercial Aspects of Drug Discovery (PGBI11076)
Course Outline
| School | School of Biological Sciences |
College | College of Science and Engineering |
| Course type | Standard |
Availability | Not available to visiting students |
| Credit level (Normal year taken) | SCQF Level 11 (Postgraduate) |
Credits | 10 |
| Home subject area | Postgraduate |
Other subject area | None |
| Course website |
None |
Taught in Gaelic? | No |
| Course description | **Online Distance Learning Course**
This course gives the student a general, illustrated overview over the different stages in drug discovery from the industrial perspective. A wide range of biotech and pharma business models will be presented and analysed including non-profit models for drug discovery through government agencies. The practicalities of starting up a new company in the biotech area will be explored and ideas and business plans for potential start up companies will be evaluated.
|
Entry Requirements (not applicable to Visiting Students)
| Pre-requisites |
|
Co-requisites | |
| Prohibited Combinations | |
Other requirements | None |
| Additional Costs | None |
Course Delivery Information
|
| Delivery period: 2014/15 Semester 2, Not available to visiting students (SS1)
|
Learn enabled: No |
Quota: None |
|
Web Timetable |
Web Timetable |
| Course Start Date |
16/02/2015 |
| Breakdown of Learning and Teaching activities (Further Info) |
Total Hours:
100
(
Online Activities 20,
Programme Level Learning and Teaching Hours 2,
Directed Learning and Independent Learning Hours
78 )
|
| Additional Notes |
|
| Breakdown of Assessment Methods (Further Info) |
Written Exam
0 %,
Coursework
100 %,
Practical Exam
0 %
|
| No Exam Information |
Summary of Intended Learning Outcomes
At the end of this course a student should have:
&· Knowledge of the cost structure of a traditional pharmaceutical corporation.
&· An understanding of the development pipeline of a major pharmaceutical corporation
&· Knowledge of the regulatory hurdles that must be passed to bring a new compound to market and the costs associated with these hurdles
&· An ability to put together and evaluate a business plan for a start-up biotech company.
|
Assessment Information
50 % group assessment (including maximum 20% variation for Peer Assessment of contribution)
50 % electronic portfolio comprising learning log and contribution to Skills Profile
|
Special Arrangements
| None |
Additional Information
| Academic description |
Not entered |
| Syllabus |
Not entered |
| Transferable skills |
Not entered |
| Reading list |
Not entered |
| Study Abroad |
Not entered |
| Study Pattern |
Not entered |
| Keywords | eCADD |
Contacts
| Course organiser | Prof Malcolm Walkinshaw
Tel: (0131 6)50 3719
Email: M.Walkinshaw@ed.ac.uk |
Course secretary | Miss Vicky Mactaggart
Tel: (0131 6)51 7052
Email: Vicky.Mactaggart@ed.ac.uk |
|
© Copyright 2014 The University of Edinburgh - 29 August 2014 4:27 am
|
University Homepage